Drugs Made In America Acquisition (DMIIR) Cash & Equivalents (2024 - 2025)
Drugs Made In America Acquisition's (DMIIR) quarterly Cash & Equivalents came in at $223.0 in Q4 2025, down 98.69% year-on-year from $17035.0 in Q4 2024, and down 99.93% on a QoQ basis from $315087.0 in Q3 2025.
Drugs Made In America Acquisition (DMIIR) Cash & Equivalents (2024 - 2025) Analysis & Trends
Drugs Made In America Acquisition (DMIIR) has 2 years of Cash & Equivalents data on file, last reported at $223.0 in Q4 2025.
- On a quarterly basis, Cash & Equivalents fell 98.69% year-over-year to $223.0 in Q4 2025; TTM through Dec 2025 was $223.0, a 98.69% decrease from a year earlier, with the FY2025 full-year figure at $223.0, down 98.69% from the prior year.
- Cash & Equivalents for Q4 2025 stood at $223.0, down from $315087.0 in the prior quarter.
- Over the last five years, Cash & Equivalents for DMIIR reached as high as $315087.0 in Q3 2025 and fell as low as $223.0 in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | EQV Ventures Acquisition | 480.75 Mn | 480.75 Mn | - | 1.47 Mn |
| 2 | Agriculture & Natural Solutions Acquisition | 393.29 Mn | 393.29 Mn | - | 1.00 |
| 3 | Berto Acquisition | 314.56 Mn | 314.35 Mn | - | 209,000.00 |
| 4 | GP-Act III Acquisition | 313.66 Mn | 313.66 Mn | - | 250,000.00 |
| 5 | Centurion Acquisition | 311.65 Mn | 311.65 Mn | - | 28,828.00 |
| 6 | Republic Digital Acquisition | 310.50 Mn | 309.63 Mn | - | 868,792.00 |
| 7 | Siddhi Acquisition Corp (Cayman Islands) | 288.97 Mn | 288.97 Mn | - | 456,983.00 |
| 8 | K&F Growth Acquisition | 283.42 Mn | 283.42 Mn | - | 577,446.00 |
| 9 | Bold Eagle Acquisition | 275.29 Mn | 275.29 Mn | - | 521,352.00 |
| 10 | Drugs Made In America Acquisition | - | - | - | 223.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 223.00 |
| Sep 30, 2025 | 315,087.00 |
| Dec 31, 2024 | 17,035.00 |